Lonza, a global manufacturing partner to the pharmaceutical, biotech and nutraceutical markets, extended its collaboration with a major biopharmaceutical partner for the commercial-scale filling of ADCs. Under the terms of the agreement, Lonza will construct a dedicated commercial-scale aseptic cGMP filling line at its Stein (CH) site. The new dedicated filling line will enable the aseptic filling of highly potent ADCs and lyophilization under containment. The additional filling capabilities ...